Multiple Sclerosis :: Fty720 – fingolimod reduces multiple sclerosis symptoms

The developmental oral therapy FTY720 (fingolimod) has demonstrated sustained benefits over two years in patients suffering from relapsing multiple sclerosis (MS), indicating that it could provide an important new option for treating this disabling neurological disease estimated to affect more than 2.5 million people worldwide.

Cancer :: UAB launches promising brain tumor trial

UAB (University of Alabama at Birmingham) researchers are investigating whether a common but usually harmless virus can be used to treat a particularly devastating type of brain tumor called malignant glioma. The virus — respiratory enteric orphan virus, or reovirus — inhabits the lungs and intestines of humans. By adulthood, most humans have been exposed to it but demonstrate no illness or effects from the infection.

Hearing Loss :: Hormone therapy tied to hearing loss in older women

The hormone progestin, as a component of hormone replacement therapy (HRT) following menopause, appears to exacerbate deficits in hearing sensitivity and auditory speech processing, according to a research team at the Rochester School of Medicine and Dentistry in New York.

Sleep Apnea :: Experts Spot New Form of Sleep Apnea

‘Complex sleep apnea’ is especially tough to treat, researchers say. Mayo Clinic researchers say they’ve identified a new type of sleep apnea called “complex sleep apnea” that may be resistant to standard treatment such as continuous positive airway pressure (CPAP).

Asthma :: Asthma tied to sleep apnea in women

Asthma appears to almost double the risk of symptoms of obstructive sleep apnea in young mothers, Ohio-based researchers report. “In a large population-based cohort of young women, we found that women with asthma are twice as likely to have symptoms of obstructive sleep apnea as compared to women without asthma,” lead investigator Dr. Maninder Kalra told.

Cholesterol :: Lipitor reduces stroke risk

In people who have experienced a stroke, but who have no known history of coronary heart disease, beginning regular treatment with the cholesterol-lowering drug atorvastatin soon after the stroke can reduce the risk of recurrent stroke by 16 percent, according to a five-year study led by an international team that includes a researcher at Duke University Medical Center.

Meditation :: The Almighty Breath – swara yoga

Would you like to know how to meditate better? How to be more effective when addressing an important personage? How to change a mood or feeling? How to be in rhythm with the universe through the day? Well, believe it or not, the answer lies in the breath. And swara yoga is the science that helps you to understand how to maximise your potential by manipulating your breath.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack